|
1
|
Žiberna L, Šamec D, Mocan A, Nabavi SF,
Bishayee A, Farooqi AA, Sureda A and Nabavi SM: Oleanolic acid
alters multiple cell signaling pathways: Implication in cancer
prevention and therapy. Int J Mol Sci. 18(643)2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ayeleso TB, Matumba MG and Mukwevho E:
Oleanolic acid and its derivatives: Biological activities and
therapeutic potential in chronic diseases. Molecules.
22(1915)2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Liu J, Zheng L, Wu N, Ma L, Zhong J, Liu G
and Lin X: Oleanolic acid induces metabolic adaptation in cancer
cells by activating the AMP-activated protein kinase pathway. J
Agric Food Chem. 62:5528–5537. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Fontana G, Bruno M, Notarbartolo M,
Labbozzetta M, Poma P, Spinella A and Rosselli S: Cytotoxicity of
oleanolic and ursolic acid derivatives toward hepatocellular
carcinoma and evaluation of NF-κB involvement. Bioorg Chem.
90(103054)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Liu J, Zheng L, Zhong J, Wu N, Liu G and
Lin X: Oleanolic acid induces protective autophagy in cancer cells
through the JNK and mTOR pathways. Oncol Rep. 32:567–572.
2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Shi Y, Song Q, Hu D, Zhuang X, Yu S and
Teng D: Oleanolic acid induced autophagic cell death in
hepatocellular carcinoma cells via PI3K/Akt/mTOR and ROS-dependent
pathway. Korean J Physiol Pharmacol. 20:237–243. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wang X, Bai H, Zhang X, Liu J, Cao P, Liao
N, Zhang W, Wang Z and Hai C: Inhibitory effect of oleanolic acid
on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest
and mitochondrial dependent apoptosis. Carcinogenesis.
34:1323–1330. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mu DW, Guo HQ, Zhou GB, Li JY and Su B:
Oleanolic acid suppresses the proliferation of human bladder cancer
by Akt/mTOR/S6K and ERK1/2 signaling. Int J Clin Exp Pathol.
8:13864–13870. 2015.PubMed/NCBI
|
|
9
|
Xu Y, Shu B, Tian Y, Wang G, Wang Y, Wang
J and Dong Y: Oleanolic acid induces osteosarcoma cell apoptosis by
inhibition of Notch signaling. Mol Carcinog. 57:896–902.
2018.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Potočnjak I, Šimić L, Vukelić I and
Domitrović R: Oleanolic acid attenuates cisplatin-induced
nephrotoxicity in mice and chemosensitizes human cervical cancer
cells to cisplatin cytotoxicity. Food Chem Toxicol.
132(110676)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li HF, Wang XA, Xiang SS, Hu YP, Jiang L,
Shu YJ, Li ML, Wu XS, Zhang F, Ye YY, et al: Oleanolic acid induces
mitochondrial-dependent apoptosis and G0/G1 phase arrest in
gallbladder cancer cells. Drug Des Devel Ther. 9:3017–3030.
2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Robey RW, Pluchino KM, Hall MD, Fojo AT,
Bates SE and Gottesman MM: Revisiting the role of ABC transporters
in multidrug-resistant cancer. Nat Rev Cancer. 18:452–464.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Dastvan R, Mishra S, Peskova YB, Nakamoto
RK and Mchaourab HS: Mechanism of allosteric modulation of
P-glycoprotein by transport substrates and inhibitors. Science.
364:689–692. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Alam A, Kowal J, Broude E, Roninson I and
Locher KP: Structural insight into substrate and inhibitor
discrimination by human P-glycoprotein. Science. 363:753–756.
2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Villar VH, Vögler O, Barceló F,
Gómez-Florit M, Martínez-Serra J, Obrador-Hevia A, Martín-Broto J,
Ruiz-Gutiérrez V and Alemany R: Oleanolic and maslinic acid
sensitize soft tissue sarcoma cells to doxorubicin by inhibiting
the multidrug resistance protein MRP-1, but not P-glycoprotein. J
Nutr Biochem. 25:429–438. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Paszel A, Rubiś B, Bednarczyk-Cwynar B,
Zaprutko L, Kaczmarek M, Hofmann J and Rybczyńska M: Oleanolic acid
derivative methyl 3,11-dioxoolean-12-en-28-olate targets multidrug
resistance related to ABCB1. Pharmacol Rep. 63:1500–1517.
2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ma W, Wang DD, Li L, Feng YK, Gu HM, Zhu
GM, Piao JH, Yang Y, Gao X and Zhang PX: Caveolin-1 plays a key
role in the oleanolic acid-induced apoptosis of HL-60 cells. Oncol
Rep. 32:293–301. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chen J, Chen Y and He Q: Action of
bleomycin is affected by bleomycin hydrolase but not by caveolin-1.
Int J Oncol. 41:2245–2252. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
He Q, Zhou W, Ji L, Zhang H, He N and Xue
S: Characteristics of harringtonine-resistant human leukemia HL60
cell. Zhongguo Yao Li Xue Bao. 17:463–467. 1996.PubMed/NCBI
|
|
20
|
Zhang J, Chen Y and He Q: Distinct
characteristics of Dasatinib-induced pyroptosis in gasdermin
E-expressing human lung cancer A549 cells and neuroblastoma SH-SY5Y
cells. Oncol Lett. 20:145–154. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nasim F, Schmid D, Szakács G, Sohail A,
Sitte HH, Chiba P and Stockner T: Active transport of rhodamine 123
by the human multidrug transporter P-glycoprotein involves two
independent outer gates. Pharmacol Res Perspect.
8(e00572)2020.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Fairchild CR, Ivy SP, Kao-Shan CS,
Whang-Peng J, Rosen N, Israel MA, Melera PW, Cowan KH and Goldsmith
ME: Isolation of amplified and overexpressed DNA sequences from
Adriamycin-resistant human breast cancer cells. Cancer Res.
47:5141–5148. 1987.PubMed/NCBI
|
|
23
|
Kaufmann SH, Desnoyers S, Ottaviano Y,
Davidson NE and Poirier GG: Specific proteolytic cleavage of
poly(ADP-ribose) polymerase: An early marker of
chemotherapy-induced apoptosis. Cancer Res. 53:3976–3985.
1993.PubMed/NCBI
|
|
24
|
Gao L, Wang Y, Xu Z, Li X, Wu J, Liu S,
Chu P, Sun Z, Sun B, Lin Y, et al: SZC017, a novel oleanolic acid
derivative, induces apoptosis and autophagy in human breast cancer
cells. Apoptosis. 20:1636–1650. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tasdemir E, Maiuri MC, Tajeddine N, Vitale
I, Criollo A, Vicencio JM, Hickman JA, Geneste O and Kroemer G:
Cell cycle-dependent induction of autophagy, mitophagy and
reticulophagy. Cell Cycle. 6:2263–2267. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Braga F, Ayres-Saraiva D, Gattass CR and
Capella MA: Oleanolic acid inhibits the activity of the multidrug
resistance protein ABCC1 (MRP1) but not of the ABCB1
(P-glycoprotein): Possible use in cancer chemotherapy. Cancer Lett.
248:147–152. 2007.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wang H, Zhong W, Zhao J, Zhang H, Zhang Q,
Liang Y, Chen S, Liu H, Zong S, Tian Y, et al: Oleanolic acid
inhibits epithelial-mesenchymal transition of hepatocellular
carcinoma by promoting iNOS dimerization. Mol Cancer Ther.
18:62–74. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chintharlapalli S, Papineni S, Konopleva
M, Andreef M, Samudio I and Safe S:
2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds
inhibit growth of colon cancer cells through peroxisome
proliferator-activated receptor gamma-dependent and -independent
pathways. Mol Pharmacol. 68:119–128. 2005.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wolf D and Rotter V: Major deletions in
the gene encoding the p53 tumor antigen cause lack of p53
expression in HL-60 cells. Proc Natl Acad Sci USA. 82:790–794.
1985.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ju JF, Banerjee D, Lenz HJ, Danenberg KD,
Schmittgen TC, Spears CP, Schönthal AH, Manno DJ, Hochhauser D,
Bertino JR, et al: Restoration of wild-type p53 activity in
p53-null HL-60 cells confers multidrug sensitivity. Clin Cancer
Res. 4:1315–1322. 1998.PubMed/NCBI
|
|
31
|
Oprean C, Ivan A, Bojin F, Cristea M,
Soica C, Drăghia L, Caunii A, Paunescu V and Tatu C: Selective in
vitro anti-melanoma activity of ursolic and oleanolic acids.
Toxicol Mech Methods. 28:148–156. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kanarek N, Petrova B and Sabatini DM:
Dietary modifications for enhanced cancer therapy. Nature.
579:507–517. 2020.PubMed/NCBI View Article : Google Scholar
|
